Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Adma Biologics (ADMA) Other financing activities: 2012-2023

Historic Other financing activities for Adma Biologics (ADMA) over the last 6 years, with Dec 2023 value amounting to $2.4 million.

  • Adma Biologics' Other financing activities rose 3265177.78% to $2.4 million in Q4 2023 from the same period last year, while for Dec 2023 it was $5.1 million, marking a year-over-year increase of 365.31%. This contributed to the annual value of $2.4 million for FY2023, which is 15.52% down from last year.
  • Adma Biologics' Other financing activities amounted to $2.4 million in FY2023, which was down 15.52% from $2.8 million recorded in FY2022.
  • Adma Biologics' Other financing activities' 5-year high stood at $2.8 million during FY2022, with a 5-year trough of $2.4 million in FY2023.
  • For the 2-year period, Adma Biologics' Other financing activities averaged around $2.6 million, with its median value being $2.6 million (2022).
  • Data for Adma Biologics' Other financing activities shows a maximum YoY dropped of 15.52% (in 2023) over the last 5 years.
  • Yearly analysis of 2 years shows Adma Biologics' Other financing activities stood at $2.8 million in 2022, then dropped by 15.52% to $2.4 million in 2023.